These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 33017580)

  • 1. Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.
    Chow CK; Atkins ER; Billot L; Chalmers J; Hillis GS; Hay P; Neal B; Nelson M; Patel A; Reid CM; Schlaich M; Usherwood T; Webster R; Rodgers A
    Am Heart J; 2021 Jan; 231():56-67. PubMed ID: 33017580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
    Chow CK; Atkins ER; Hillis GS; Nelson MR; Reid CM; Schlaich MP; Hay P; Rogers K; Billot L; Burke M; Chalmers J; Neal B; Patel A; Usherwood T; Webster R; Rodgers A;
    Lancet; 2021 Sep; 398(10305):1043-1052. PubMed ID: 34469767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
    Chow CK; Thakkar J; Bennett A; Hillis G; Burke M; Usherwood T; Vo K; Rogers K; Atkins E; Webster R; Chou M; Dehbi HM; Salam A; Patel A; Neal B; Peiris D; Krum H; Chalmers J; Nelson M; Reid CM; Woodward M; Hilmer S; Thom S; Rodgers A
    Lancet; 2017 Mar; 389(10073):1035-1042. PubMed ID: 28190578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial.
    Huffman MD; Baldridge AS; Lazar D; Abbas H; Mejia J; Flowers FM; Quintana A; Jackson A; Kandula NR; Lloyd-Jones DM; Persell SD; Khan SS; Paparello JJ; Chopra A; Tripathi P; Vu MH; Chow CK; Ciolino JD
    Hypertens Res; 2024 Jun; 47(6):1668-1677. PubMed ID: 38584159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.
    Nolde JM; Atkins E; Marschner S; Hillis GS; Chalmers J; Billiot L; Nelson MR; Reid CM; Hay P; Burke M; Jansen S; Usherwood T; Rodgers A; Chow CK; Schlaich MP
    J Hypertens; 2024 Jun; 42(6):1009-1018. PubMed ID: 38501351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
    Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
    J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
    Zhao X; Chen Y; Yang G; Li X; Tang X; Yang Q; Peng L; Li J; Liang Z; Li A; Wang W; Huang M; Liu T; Li X; Jiang W
    Am Heart J; 2023 Oct; 264():10-19. PubMed ID: 37276913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial.
    Baldridge AS; Huffman MD; Lazar D; Abbas H; Flowers FM; Quintana A; Jackson A; Khan SS; Chopra A; Vu M; Tripathi P; Jacobson T; Sanuade OA; Kandula NR; Persell SD; Paparello JJ; Rosul LL; Mejia J; Lloyd-Jones DM; Chow CK; Ciolino JD
    Am Heart J; 2022 Dec; 254():183-193. PubMed ID: 36116516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): statistical analysis plan for a randomized, blinded, crossover trial.
    Zhao X; Li X; Liu T; Yang G; Chen Y; Huang M; Zhao L; Li X; Jiang W
    Trials; 2024 Jan; 25(1):45. PubMed ID: 38218924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ
    Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure control with a single-pill combination of indapamide sustained-release and amlodipine in patients with hypertension: the EFFICIENT study.
    Jadhav U; Hiremath J; Namjoshi DJ; Gujral VK; Tripathi KK; Siraj M; Shamanna P; Safar M
    PLoS One; 2014; 9(4):e92955. PubMed ID: 24714044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension.
    Poulter NR; Dolan E; Gupta AK; O'Brien E; Whitehouse A; Sever PS
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):313-323. PubMed ID: 30919249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
    Okamura K; Shirai K; Totake N; Okuda T; Urata H
    Clin Exp Hypertens; 2018; 40(2):99-106. PubMed ID: 28692311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.